1. Peale NV. The Power of Positive Thinking. New York: Simon & Schuster; 1952. republished in 1980.
2. Leserman J. Role of depression, stress, and trauma in HIV disease progression. Psychosom Med. 2008;70:539–545. [PubMed] 3. Temoshok LR, Wald RL, Synowski S, Garzino-Demo A. Coping as a multisystem construct associated with pathways mediating HIV-relevant immune function and disease progression. Psychosom Med. 2008;70:555–561. [PubMed] 4. Chesney MA, Darbes LA, Hoerster K, Taylor JM, Chambers DB, Anderson DE. Positive emotions: exploring the other hemisphere in behavioral medicine. Int J Behav Med. 2005;12:50–58. [PubMed]
5. Snyder CR, Lopez SJ. New York: Oxford University Press; 2002. Handbook of Positive Psychology.
6. Ickovics JR, Milan S, Boland R, Schoenbaum E, Schuman P, Vlahov D. Psychological resources protect health 5-year survival and immune function among HIV-infected women from four US cities. AIDS. 2006;20:1851–1860. [PubMed]
7. Milam JE, Richardson JL, Marks G, Kemper CA, McCuthchan AJ. The roles of dispositional optimism and pessimism in HIV disease progression. Psychol Health. 2004;19:167–181.
8. Ironson G, Balbin E, Stuetzle R, Fletcher MA, O’Cleirigh C, Laurenceau JP, Schneiderman N, Solomon G. Dispositional optimism and the mechanisms by which it predicts slower disease progression in HIV: proactive behavior, avoidant coping, and depression. Int J Behav med. 2005;12:86–97. [PMC free article] [PubMed] 9. Blomkvist V, Theorell T, Jonsson H, Schubnan S, Berntorp E, Stiegendal L. Psychosocial self-prognosis in relation to mortality and morbidity in hemophiliacs with HIV infection. Psychother Psychosom. 1994;62:185–192. [PubMed] 10. Reed GM, Kemeny ME, Taylor SE, Wang HJ, Visscher BR. Realistic acceptance as a predictor of decreased survival time in gay men with AIDS. Health Psychol. 1994;13:299–307. [PubMed] 11. Tomakowsky J, Lumley MA, Markowitz N, Frank C. Optimism explanatory style and dispositional optimism in HIV-infected men. J Psychosom Res. 2001;51:577–587. [PubMed] 12. Moskowitz J. Positive affect predicts lower risk of AIDS mortality. Psychosom Med. 2003;65:620–626. [PubMed]
13. Moskowitz J, Carrico A, Acree M. Positive affect predicts greater CD4 response to HIV treatment. Presented at the American Psychosomatic Society meeting; Budapest, Hungary. 2007. Mar,
14. Bower BE, Kemeny ME, Taylor SE. Cognitive processing, discovery of meaning, CD4 decline, and AIDS-related mortality among bereaved HIV-seropositive men. J Consult Clin Psychol. 1998;66:979–986. [PubMed] 15. Mulder CL, Antoni MH, Duivenvoorden HJ, Kauffmann RH, Goodkin K. Active confrontational coping predicts decreased clinical progression over a one-year period in HIV-infected homosexual men. J Psychosom Res. 1995;39:957–965. [PubMed] 16. Vassend O, Eskild A. Psychological distress, coping, and disease progression in HIV-positive homosexual men. J Health Psychol. 1998;3:243–257. [PubMed] 17. Thornton S, Troop M, Burgess AP, Button J, Goodall R, Flynn R, Gazzard BG, Catalán J, Easterbrook PJ. The relationship of psychological variables and disease progression among long-term HIV-infected men. Int J STD AIDS. 2000;11:734–742. [PubMed] 18. Ironson G, Stuetzle R, Fletcher MA. An increase in religiousness/spirituality occurs after HIV diagnosis and predicts slower disease progression over 4 years in people with HIV. J Gen Intern Med. 2006;21:S62–S68. [PMC free article] [PubMed] 19. Fitzpatrick AL, Standish LJ, Berger J, Kim J, Calabrese C, Polissar N. Survival in HIV-1 positive adults practicing psychological or spiritual activities for one year. Altern Ther Health Med. 2007;13:18–24. [PubMed] 20. Ironson G, Kremer H. Spiritual transformations in people with HIV predicts lower mortality. Paper presented at the annual meeting of the American Psychosomatic Society; March 12–15, 2008; Baltimore, Maryland. [Accessed April 28, 2008]. Available at: http://www.psychosomaticmedicine.org/misc/TotalAbstractBook.pdf.
21. Ironson G, Stuezle R, Fletcher MA, Ironson D. View of God is associated with disease progression in HIV. Paper presented at the annual meeting of the Society of Behavioral Medicine; March 22–25, 2006; San Francisco, California. 2006. p. S074. Abstract published in Ann Behav Med.
22. Tedeschi RG, Calhoun LG. Trauma and Transformation: Growing in the Aftermath of Suffering. Thousand Oaks CA: Sage; 1995.
23. Calhoun LG, Tedeschi RG. Handbook of Posttraumatic Growth. Mahwah, NJ: Lawrence Erlbaum Associates; 2006.
24. Milam J. Posttraumatic growth and HIV disease progression. J Consult Clin Psychol. 2006;74:817–827. [PubMed] 25. O’Cleirigh C, Ironson G, Antoni M, Fletcher MA, McGuffey L, Balbin E, Schneiderman N, Solomon G. Emotional expression and depth processing of trauma and their relation to long-term survival in patients with HIV/AIDS. J Psychosom Res. 2003;54:225–235. [PubMed] 26. O’Cleirigh C, Ironson G, Solomon G, Balbin E, Schneiderman N, Fletcher MA. Depth processing of traumatic life experiences predicts HIV disease progression (CD4 and viral load) at 2 year follow-up. Presented at the annual conference of the American Psychosomatic Society; Phoenix, Arizona. 2003. Mar, Available at: http://www.psychosomaticmedicine.org/cgi/data/65/1/DC1/1. 27. Ironson G, O’Cleirigh C, Fletcher MA, Laurenceau JP, Balbin E, Klimas N, Schneiderman N, Solomon G. Psychosocial factors predict CD4 and viral load change in men and women in the era of HAART. Psychosom Med. 2005;67:1013–1021. [PMC free article] [PubMed]
28. Solano L, Costa M, Temoshok L, Salvati S, Coda R, Aiuti F, Di Sora F, D’Offizi G, Figa-Talamanca L, Mezzaroma I, Montellax F, Bertini M. An emotionally inexpressive (type C) coping style influences HIV disease progression at six and twelve month follow-ups. Psychol Health. 2002 17;:641–655.
29. Cole SW, Korin YD, Fahey JL, Zack JA. Norepinephrine accelerates HIV replication via protein kinase A-dependent effects on cytokine production. J Immunol. 1998;161:610–616. [PubMed] 30. Ashton E, Vosvick M, Chesney M, Gore-Felton C, Koopman C, O’Shea K, Maldonado J, Bachmann MH, Israelski D, Flamm J, Spiegel D. Social support and maladaptive coping as predictors of the change in physical health symptoms among persons living with HIV/AIDS. AIDS Patient Care STDs. 2005;19:587–598. [PubMed]
31. Costa PT, McCrae RR. The NEO Personality Inventory Manual. Odessa, FL: Psychological Assessment Resources, Inc.; 1985.
32. Costa PT, McCrae RR. Revised NEO Personality Inventory (NEO-PI-R) and NEO Five-Factor Inventory (NEO-FFI) Professional Manual. Odessa, FL: Psychological Assessment Resources, Inc.; 1992.
33. O’Cleirigh C, Ironson G, Weiss A, Costa P. Conscientiousness predicts disease progression (CD4 number and viral load) in people living with HIV. Health Psychol. 2007;26:473–480. [PubMed] 34. Ironson G, O’Cleirigh C, Weiss A, Schneiderman N, Costa P. Personality and HIV disease progression over 4 years: the role of NEO PI-R openness, extraversion, and profiles of engagement. Psychosom Med. 2008;70:245–253. [PMC free article] [PubMed]
35. Ironson G. Altruism and Health in HIV. In: Post SG, editor. Altruism and Health. New York: Oxford University Press; 2007.
36. Ironson G, Weiss S, Lydston D, Ishii M, Jones D, Asthana D, Tobin J, Lechner S, LaPerriere A, Schneiderman N, Antoni M. The impact of improved self-efficacy on HIV viral load and distress in culturally diverse women living with AIDS: the SMART/EST women’s project. AIDS Care. 2005;17:222–236. [PubMed] 37. Ironson G, Friedman A, Klimas N, Antoni M, Fletcher MA, LaPerriere A, Simoneau J, Schneiderman N. Distress, denial, and low adherence to behavioral interventions predict faster disease progression in HIV-1 infected gay men. Int J Behav Med. 1994;1:90–105. [PubMed] 38. Miller GE, Kemeny ME, Taylor SE, Cole SW, Visscher BR. Social relationships and immune processes in HIV seropositive gay and bisexual men. Ann Behav Med. 1997;19:139–151. [PubMed] 39. Patterson TL, Shaw WS, Semple SJ, Cherner M, McCutchan JA, Atkinson JH, Grant I, Nannis E. Relationship of psychosocial factors to HIV disease progression. Ann Behav Med. 1996;18:30–39. [PubMed] 40. Leserman J, Jackson ED, Petitto JM, Golden RN, Silva SG, Perkins DO, Cai J, Folds JD, Evan DL. Progression to AIDS: the effects of stress, depressive symptoms, and social support. Psychosom Med. 1999;61:397–406. [PubMed] 41. Leserman J, Petitto JM, Golden RN, Gaynes BN, Gu H, Perkins DO, Silva SG, Folds JD, Evans DL. Impact of stressful life events, depression, social support, coping, and cortisol on progression to AIDS. Am J Psychiatry. 2000;157:1221–1228. [PubMed] 42. Leserman J, Petitto JM, Gu H, Gaynes BN, Barroso J, Golden RN, Perkins DO, Folds JD, Evans DL. Progression to AIDS, a clinical AIDS condition and mortality: psychosocial and physiological predictors. Psychol Med. 2002;32:1059–1073. [PubMed] 43. Solano L, Costa M, Salvati S, Coda R, Aiuti F, Mezzaroma I, Bertini M. Psychosocial factors and clinical evolution in HIV-infection: a longitudinal study. J Psychosom Res. 1993;37:39–51. [PubMed] 44. Theorell T, Blomkvist V, Jonsson H, Schulman S, Berntorp E, Stigendal L. Social support and the development of immune function in human immunodeficiency virus infection. Psychosom Med. 1995;57:32–36. [PubMed] 45. Perry S, Fishman B, Jacobsberg L, Frances A. Relationships over 1 year between lymphocyte subsets and psychosocial variables among adults with infection by human immunodeficiency virus. Arch Gen Psychiatry. 1992;49:396–401. [PubMed] 46. Eich-Hochli E, Niklowitz MW, Luthy R, Opravil M. Are immunological markers, social and personal resources, or a complaint-free state predictors of progression among HIV-infected patients? Acta Psychiatr Scand. 1997;95:476–484. [PubMed] 47. Holmes WC, Pace JL. HIV-seropositive individualsx02019; optimistic beliefs about prognosis and relation to medication and safe sex adherence. J Gen Intern Med. 2002;17:677–683. [PMC free article] [PubMed] 48. Miller GE, Cole SW. Social relationships and the progression of human immunodeficiency virus infection: a review of evidence and possible underlying mechanisms. Ann Behav Med. 1998;20:181–189. [PubMed]
49. Chang EC. Dispositional optimism and primary and secondary appraisal of a stressor: controlling for confounding influences and relations to coping and psychological and physical adjustment. J Pers Soc Psychol. 1998;74:1109–1120.
50. Pressman S, Cohen S. Does positive affect influence health? Psychol Bull. 2005;131:925–971. [PubMed]
51. Pennebaker JW, Chung CK. Expressive writing, emotional upheavals, and health. In: Friedman HS, Silver RC, editors. Foundations of Health Psychology. New York: Oxford University Press; 2007.
52. Post SG, editor. Altruism and Health. New York: Oxford University Press; 2007.
53. Taylor S, Kemeny M, Reed G, Bower J, Gruenewald T. Psychological resources, positive illusions, and health. Am Psychol. 2000;55:99–109. [PubMed] 54. Lyubomirsky S, King L, Diener E. The benefits of frequent positive affect: does happiness lead to success? Psychol Bull. 2005;131:803–855. [PubMed]
55. Bandura A. Self-Efficacy: The Exercise of Control. New York: W. H. Freeman & Company; 1997.
56. Plante TG, Thoresen CE, editors. Spirit, Science, and Health: How the Spiritual Mind Fuels Physical Wellness. Portsmouth, NH: Greenwood Publishing Group; 2007.
57. Kremer H, Ironson G. Spirituality and health in HIV. In: Plante T, Thoresen C, editors. How the Spiritual Mind Fuels Physical Wellness. Portsmouth, NH: Greenwood Publishing Group; 2007.
58. Uchino BN. Social Support and Physical Health: Understanding the Health Consequences of Relationships. New Haven: Yale University Press; 2004.
59. Uchino BN. J Behav Med. Vol. 29. 2006. Social support and health: a review of physiological processes potentially underlying links to disease outcomes; pp. 377–387. [PubMed] 60. Cohen S. Psychosocial models of the role of social support in the etiology of physical disease. Health Psychol. 1988;7:269–297. [PubMed] 61. Berkman LF. Social support, social networks, social cohesion and health. Soc Work Health Care. 2000;31:3–14. [PubMed] 62. Hibbard JH, Pope CR. The quality of social roles as predictors of morbidity and mortality. Soc Sci Med. 1993;36:217–225. [PubMed] 63. Lee M, Rotheram-Borus MJ. Challenges associated with increased survival among parents living with HIV. Am J Pub Health. 2001;91:1303–1309. [PubMed] 64. Barroso J, Buchanan D, Tomlinson P, Van Servellen G. Social support and long-term survivors of AIDS. West J Nurs. 1997;19:554. [PubMed]
65. Barroso J. Reconstructing my life: becoming a long-term survivor of AIDS. Qualitative Health Research. 1997;7:57–74.
66. Folkman S. Positive psychological states and coping with severe stress. Soc Sci Med. 1997;45:1207–1221. [PubMed] 67. Folkman S, Moskowitz JT. Positive affect and the other side of coping. Am Psychol. 2000;55:647–654. [PubMed] 68. Mayne TJ, Vittinghoff E, Chesney MA, Barrett DC, Coates TJ. Depressive affect and survival among gay and bisexual men infected with HIV. Arch Intern Med. 1996;156:2233–2238. [PubMed] 69. Ickovics JR, Hamburger ME, Vlahov D, Schoenbaum EE, Schuman P, Boland RJ, Moore J. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV epidemiological research study. JAMA. 2001;285:1466–1474. [PubMed] 70. Seligman MEP, Csikszentmihalyi M. Positive psychology: an introduction. Am Psychol. 2000;55:5–14. [PubMed]
71. Peterson C, Seligman MEP. Washington, DC: American Psychological Association; 2004. Character Strengths and Virtues: A Handbook and Classification.
72. Bonnano G. Loss, trauma, and human resilience: have we underestimated the human capacity to thrive after extremely aversive events? Am Psychol. 2004;59:20–28. [PubMed] 73. Masten AS, Coatsworth JD. The development of competence in favorable and unfavorable environments: lessons from research on successful children. Am Psychol. 1998;53:205–220. [PubMed]
74. Ryff CD, Singer B. From social structure to biology: integrative science in pursuit of human health and well-being. In: Snyder CR, Lopez SJ, editors. Handbook of Positive Psychology. New York: Oxford University Press; 2002.
75. Lazarus R, Folkman S. Stress, Appraisal, and Coping. New York: Springer; 1984.
76. Simons JS, Gaher RM. The distress tolerance scale: development and validation of a self-report measure. Motiv Emot. 2005;29:83–102.
77. O’Cleirigh C, Ironson G, Smits J. Does distress tolerance moderate the impact of major life events on psychosocial variables and behaviors important in the management of HIV? Behav Ther. 2007:314–323. [PMC free article] [PubMed]
78. Geary DC. Male, Female: The Evolution of Human Sex Differences. Washington, DC: American Psychological Association; 1998.
79. Tsevat J, Sherman S, McElwee J, Mandell K, Simbartl L, Sonnenberg F, Fowler FJ. The will to live among HIV-infected patients. Ann Intern Med. 1999;111(131):194–198. [PubMed] 80. Schneiderman N, Ironson G, Siegel S. Stress and health: psychological, behavioral and biological determinants. Ann Rev Clin Psychol. 2005;1:607–628. [PMC free article] [PubMed]
81. Temoshok L. On biobehavioral models of cancer stress and disease course. Am Psychol. 1995;50:1104–1105.
82. Gore-Felton C, Koopman C. Behavioral mediation of the relationship between psychosocial factors and HIV disease progression. Psychosom Med. 2008;70:569–574. [PubMed] 83. Cole SW. Psychosocial influences on HIV disease progression: neural, endocrine and virologic mechanisms. Psychosom Med. 2008;70:562–568. [PubMed] 84. Taylor SE, Kemeny ME, Aspinwall LG, Schneider SG, Rodrigez R, Herbert M. Optimism, coping, psychological distress, and high-risk sexual behavior among men at risk for acquired immunodeficiency syndrome (AIDS) J Pers Soc Psychol. 1992;63:460–473. [PubMed] 85. Gonzalez JS, Penedo FJ, Antoni MH, Duran RE, Fernandez MI, McPherson-Baker S, Ironson G, Klimas N, Fletcher MA, Schneiderman N. Social support, positive states of mind, and HIV treatment adherence in men and women living with HIV/AIDS. Health Psychol. 2004;23:413–418. [PubMed] 86. Perkins DO, Leserman J, Murphy C, Evans DL. Psychosocial predictors of high-risk sexual behavior among HIV-negative homosexual men. AIDS Educ Prev. 1993;5:141–152. [PubMed] 87. Ironson G, Solomon GF, Balbin EG, O’Cleirigh C, George A, Kumar M, Larson D, Woods TE. The Ironson-Woods spirituality/religiousness index is associated with long survival, health behaviors, less distress, and low cortisol in people with HIV/AIDS. Ann Behav Med. 2002;24:34–48. [PubMed] 88. Simoni J, Frick PA, Huang B. A longitudinal evaluation of a social support model of medication adherence among HIV-positive men and women on antiretroviral therapy. Health Psychol. 2006;25:74–81. [PubMed]
89. Temoshok L, Wald R. Forgiveness and health implications in persons living with HIV/AIDS. Ann Behav Med. 2006;31:S032.
90. Kremer H, Ironson G, Schneiderman N, Hautzinger M. To take or not to take: decision-making about antiretroviral treatment in people living with HIV/AIDS. AIDS Patient Care STDs. 2006;20:335–349. [PMC free article] [PubMed] 91. Remien RH, Stirratt MJ, Dognin J, Day E, El-Bassel N, Warne PJ. Moving from theory to research to practice: implementing an effective dyadic intervention to improve antiretroviral adherence for clinic patients. J Acquir Immune Defic Syndr. 2006;43:69–78. [PubMed]
92. Cacioppo JT, Hawkley LC, Berntson GG. The anatomy of loneliness. Curr Dir Psychol Sci. 2003;12:71–74.
93. Taylor SE, Dickerson SS, Klein LC. Toward a biology of social support. In: Snyder CR, Lopez SJ, editors. Handbook of Positive Psychology. New York: Oxford University Press; 2002.
94. Taylor SE, Klein LC, Lewis BP, Gruenewald TL, Gurung RA, Updegraff JA. Biobehavioral responses to stress in females: tend-and-befriend, not fight-or-flight. Psychol Rev. 2000;107:411–429. [PubMed] 95. Carrico A, Ironson G, Antoni M, Lechner S, Duran R, Kumar M, Schneiderman N. A path model of the effects of spirituality on depressive symptoms and 24-hour urinary free cortisol in HIV-positive patients. J Psychosom Res. 2006;61:51–58. [PubMed] 96. Ironson G, Balbin E, Stieren E, Detz K, Fletcher MA, Schneiderman N, Kumar M. Int J Behav Med. 3. Vol. 15. 2008. Perceived stress and norepinephrine predict the effectiveness of viral load response to protease inhibitors in HIV. In press. [PMC free article] [PubMed]
97. Cacioppo JT, Hawkley LC, Rickett EM. Sociality, spirituality, and meaning making: Chicago health, aging, and social relations study. Rev Gen Psychol. 2005;9:143–155.
98. Coan J, Schaefer H, Davidson R. Lending a hand: social regulation of the neural response to threat. Psychol Sci. 2006;17:1032–1039. [PubMed] 99. Segerstrom SC. Optimism, goal conflict, and stressor-related immune change. J Behav Med. 2001;24:441–467. [PubMed] 100. Alter G, Altfeld M. NK cell function in HIV-1 infection. Curr Mol Med. 2006;6:621–629. [PubMed] 101. Ironson G, Balbin E, Solomon G, Fahey J, Klimas N, Schneiderman N, Fletcher MA. Relative preservation of natural killer cell cytotoxicity and number in healthy AIDS patients with low CD4 counts. AIDS. 2001;15:2065–2073. [PubMed] 102. O’Cleirigh C, Ironson G, Fletcher MA, Schneiderman N. Written emotional disclosure and processing of trauma are associated with protected health status and immunity in people living with HIV/AIDS. Br J Health Psychol. 2008;13(1):81–84. [PMC free article] [PubMed] 103. Goodkin K, Blaney NT, Feaster D, Fletcher MA, Baum MK, Mantero-Atienza E, Klimas NG, Millon C, Szapocznik J, Eisdorfer C. Active coping style is associated with natural killer cell toxicity in asymptomatic HIV-1 seropositive homosexual men. J Psychosom Res. 1992;36:635–650. [PubMed] 104. Temoshok LR, Waldstein SR, Wald RL, Garzino-Demo A, Synowski S, Sun L, Wiley JA. Type C coping, alexithymia, and heart rate reactivity are associated independently and differentially with specific immune mechanisms linked to HIV progression. Brain Behav Immun. 2008 Mar 16; [Epub ahead of print] 2008.02.003. [PubMed] 105. Carrico AW, Antoni MH. Effects of psychological interventions on neuroendocrine hormone regulation and immune status in HIV-positive persons: a review of randomized controlled trials. Psychosom Med. 2008;70:575–584. [PMC free article] [PubMed] 106. Chesney MA, Chambers DB, Taylor JM, Johnson LM, Folkman S. Coping effectiveness training for men living with HIV: results from a randomized clinical trial testing a group-based intervention. Psychosom Med. 2003;65:1038–1046. [PubMed]
107. Antoni M, Ironson G, Schneiderman N. New York: Oxford University Press; 2007. Stress Management for HIV: Intervention Manual and Participant Workbook.
108. Antoni MH, Lehman JM, Klibourn KM. Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early-stage breast cancer. Health Psychol. 2001;20:20–32. [PubMed] 109. Lutgendorf S, Antoni M, Ironson G, Starr K, Costello N, Zuckerman M, Klimas N, Fletcher MA, Schneiderman N. Changes in cognitive coping skills and social support mediate distress outcomes in symptomatic HIV-positive gay men during a cognitive behavioral stress management intervention. Psychosom Med. 1998;60:204–214. [PubMed]
110. Cruess S, Antoni MH, Hayes A. Changes in mood and depressive symptoms and related chang processes during cognitive-behavioral stress management in HIV-infected men. Cog Ther Res. 2002;26:373–392.
111. Antoni M, Cruess S, Cruess D, Kumar M, Lutgendorf S, Ironson G, Dettmer E, Williams J, Klimas N, Fletcher MA, Schneiderman N. Cognitive behavioral stress management reduces distress and 24 hour urinary free cortisol among symptomatic HIV-infected gay men. Ann Behav Med. 2000;22:29–37. [PubMed] 112. Antoni MH, Cruess D, Wagner S, Lutgendorf S, Kumar M, Ironson G, Klimas N, Fletcher MA, Schneiderman N. Cognitive behavioral stress management effects on anxiety, 24-hour urinary catecholamine output, and T cytotoxic/suppressor cells over time among symptomatic HIV-infected gay men. J Consult Clin Psychol. 2000;68:31–45. [PubMed] 113. Antoni M, Caricco A, Duran R, Spitzer S, Penedo F, Ironson G, Fletcher MA, Klimas N, Schneiderman N. Randomized clinical trial of cognitive behavioral stress management on HIV viral load in gay men treated with HAART. Psychosom Med. 2006;68:143–151. [PubMed] 114. Cruess S, Antoni MH, Cruess D, Fletcher MA, Ironson G, Kumar M, Lutgendorf, Hayes A, Klimas N, Schneiderman N. Reductions in herpes simplex virus type 2 antibody titers after cognitive behavioral stress management and relationships with neuroendocrine function, relaxation skills, and social support in HIV-positive men. Psychosom Med. 2000;62:828–837. [PubMed] 115. Petrie KJ, Fontanilla I, Thomas MG, Booth R, Pennebaker J. Effect of written emotional expression on immune function in patients with human immunodeficiency virus infections: a randomized trial. Psychosom Med. 2004;66:272–275. [PubMed]
116. Ironson G, Leserman J, O’Cleirigh C. The effect of emotional expression through writing in HIV. Paper presented at the International Congress of Behavioral Medicine; Dec 2–5, 2006; Bangkok, Thailand.
117. Tuck I, Alleyne R, Thinganjana W. Spirituality and stress management in healthy adults. J Holist Nurs. 2006;24:245–253. [PubMed] 118. McCain NL, Gray DP, Elswick RK, Robins JW, Tuck I, Walter JM, Rausch SM, Ketchum JM. J Consult Clin Psychol. A randomized clinical trial of alternative stress management interventions in persons with HIV. In press. [PubMed] 119. Gerbert B, Danley DW, Herzig K, Clanon K, Ciccarone D, Gilbert P, Allerton M. Reframing “prevention with the positives”: incorporating counseling techniques that improve the health of HIV-positive patients. AIDS Patient Care STDS. 2006;20:19–28. [PMC free article] [PubMed]
120. Segerstrom SC, Castenada J, Spencer TE. Optimism effects on cellular immunity: testing the affective and persistence models. Pers Individ Dif. 2003;35:1615–1624.
121. Monat R, Lazarus RA. Stress and coping: some current issues and controversies. In: Monat A, Lazarua RS, editors. Stress and Coping. An Anthology. 3rd ed. New York: Columbia University Press; 1991.
122. Kristeller JL, Rhodes M, Cripe LD, Sheets V. Oncologist assisted spiritual intervention study (OASIS): patient acceptability and initial evidence of effects. Int J Psychiatr Med. 2005;35:329–347. [PubMed]